Total Funding
24
3
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
39773
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Acquired by 
Exact Sciences
- Matt Franklin: Chief Commercial Officer
- Kenneth Kinzler: Founder
About the Company
Thrive is a healthcare company focused on saving lives by making earlier detection of cancer a routine part of medical care.
It develops CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of the disease. CancerSEEK will serve as the core of Thrive’s integrated cancer information offering.
The company was
launched in 2019 by Third Rock Ventures, with funding from additional investors Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3.
